Allergan commits more to Irish operations

Ireland-headquartered drugmaker Allergan (NYSE: AGN) has shown its commitment to its home country by pledging 65 million euros ($73 million) for the continued expansion of the company’s laboratories and manufacturing sites at Westport in County Mayo and Clonshaugh in north Dublin.

The Westport facility (pictured above) has created 63 new jobs, bringing Allergan’s total workforce in Ireland to more than 2,000 across the country. As many as one in ten of the company’s workers is based in Ireland, where the firm has four facilities.

Allergan’s Westport campus is the largest and most sophisticated of the company’s global network. Encompassing a pharmaceuticals facility, two biologics plants and an ocular implant facility, it is responsible for the global supply of flagship Allergan product Botox (botulinum toxin) and manufactures a range of eye care products.